503A compounding operations in hospitals and health systems could be subject to FDA inspection—some already are…

Health-system pharmacists who compound medications just for their own patients are accustomed to periodic inspections by state boards of pharmacy, the Joint Commission or other groups. But some pharmacies have found themselves under scrutiny in the past year or so by a more powerful regulator: the FDA.

Read the full article — 503A Facilities Could Be Subject to FDA Inspection — on Pharmacy Practice News.